An prospective and observational study of comparison of efficacy and tolerability between metformin and combination of metformin and glibenclamide in the maintence therapy of type 2 diabetes mellitus in a tertiary care hospital

Abstract

Background Diabetes mellitus is one of the most common non-communicable disease world-wide. There are many groups of drugs available for the treatment of type 2 diabetes mellitus. we use these drugs as monotherapy or in combination to maintain normoglycemia. Because of paucity of published reports in the Indian literature regarding the pattern of use, efficacy, safety, tolerability of comparison of therapy of metformin and combination of metformin and glibenclamide, the present study was taken up. Objectives To study the comparison of efficacy, safety and tolerability of metformin and combination of metformin and glibenclamide in achieving normal blood glucose level in type 2 diabetes mellitus. Materials and methods 100 properly selected subjects with type 2 diabetes mellitus were included for the present study. The medication were used empirically as monotherapy or fixed dose combination, OD or BID in a continuation manner after the meals. Blood glucose level was measured at the baseline and daily afterwards for one month using standard techniques. The data collected was analyzed statistically using descriptive statistics. Tolerability and patient compliance for the prescribed medications were also assessed during the follow up visits. Results Combination therapy reported to control the blood glucose level more efficiently as compared to metformin monotherapy at the end of the study, as 96% of subjects showed normoglycemia as compared to metformin (70%). Also, incidence of hyperglycemic episodes were less in combination therapy. Subjects with combination therapy reported more side effects compared to metformin alone therapy. The patient compliance for the prescribed medications was excellent. Interpretation and Conclusion Blood glucose level can be effectively maintained under normal limits in Type 2 DM, with combination therapy as compared to monotherapy of metformin.

Authors and Affiliations

Dr. Syed Wasif

Keywords

Related Articles

Free radical scavenging and protease inhibitory activities of Datura stramonium L

It is generally accepted that proteolytic enzymes are involved in the catabolic aspect of normal tissue remodeling and that altered activity of these enzymes is responsible for cartilage destruction and bone erosion as...

Anticancer potential of Polyalthia longifolia fruits in DEN/PB induced hepatocellular carcinoma (HCC) in rats

This study was designed to evaluate the anticancer potential of methanolic extract of fruits of Polyalthia longifolia(MEFPL)in N-nitrosodiethylamine (DEN) induced and phenobarbital (PB) promoted hepatocellular carcinom...

Studies on the hydrobiological parameters and the distribution of nutrients in (grand anaicut and lower anaicut) the river cauvery, thanjavur, Tamil nadu, India

The present investigation on the hydrobiological and distribution of nutrients in various seasons at Grand Anaicut and Lower Anaicut (Stations I and II) reservoir of River Cauvery were thoroughly studied during July 201...

Evaluation of antidiabetic activity of abelmoschus esculentus in streptozotocin induced diabetic rats

Background Abelmoschus esculentus is traditionally well known for its versatile uses. The present study was carried out to evaluate the antidiabetic action of ethanolic extract of Abelmoschus esculentus in Streptozotoci...

A review on traditional ayurvedic medicinal plants used in the sundarban mangrove forest in bangladesh

Medicinal Plants have been used for thousands of years to flavor and conserve food, to treat health disorders and to prevent diseases including epidemics. Recently, dramatic changes have taken place in the primary healt...

Download PDF file
  • EP ID EP413209
  • DOI -
  • Views 140
  • Downloads 0

How To Cite

Dr. Syed Wasif (2018). An prospective and observational study of comparison of efficacy and tolerability between metformin and combination of metformin and glibenclamide in the maintence therapy of type 2 diabetes mellitus in a tertiary care hospital. International Journal of Research in Pharmacology & Pharmacotherapeutics (IJRPP), 7(1), 69-79. https://europub.co.uk/articles/-A-413209